{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:12:34Z","timestamp":1789708354868,"version":"4.0.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a rare form of aggressive B-cell lymphoma with limited molecular information reported regarding interferon regulatory factor 4 (<jats:italic toggle=\"yes\">IRF4<\/jats:italic>) status. Here, we presented 3 EBV-positive DLBCL cases with <jats:italic toggle=\"yes\">IRF4<\/jats:italic> rearrangement (EBV+DLBCL-<jats:italic toggle=\"yes\">IRF4<\/jats:italic>-R) verified by fluorescence in situ hybridization (FISH). Three patients, including 1 male and 2 females (median age: 64\u00a0y; range: 45 to 68\u00a0y), had normal immune function. During a median follow-up of 12 months (range: 0 to 24 mo), 2 patients succumbed to the disease, and 1 patient achieved complete response. Three tumors were present in the mediastinum, stomach, and thalamus, respectively. All three tumors exhibited DLBCL morphology and were identified as the non-germinal center B-cell subtype, with EBV-encoded small RNA positivity ranging from 70% to 80%. RNA sequencing was able to identify <jats:italic toggle=\"yes\">RHOH<\/jats:italic> and <jats:italic toggle=\"yes\">IGH<\/jats:italic> as fusion partners of <jats:italic toggle=\"yes\">IRF4<\/jats:italic> in two cases. No <jats:italic toggle=\"yes\">MYC<\/jats:italic> and <jats:italic toggle=\"yes\">BCL2<\/jats:italic> rearrangements were detected in 3 cases by FISH and RNA sequencing. Next-generation sequencing revealed a low mutation burden, and only <jats:italic toggle=\"yes\">IRF4<\/jats:italic> was recurrently mutated in two EBV+DLBCL-<jats:italic toggle=\"yes\">IRF4<\/jats:italic>-R cases. Using the LymphGen 2.0 classifier, 1 case was classified as the MCD (including <jats:italic toggle=\"yes\">MYD88<\/jats:italic>\n                           <jats:sup>L265P<\/jats:sup> and <jats:italic toggle=\"yes\">CD79B<\/jats:italic> mutations) subtype. We report rare EBV+DLBCL-<jats:italic toggle=\"yes\">IRF4<\/jats:italic>-R that may enhance our understanding of the diverse spectrum of large B-cell lymphoma.<\/jats:p>","DOI":"10.1097\/pas.0000000000002301","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:01:13Z","timestamp":1724382073000},"page":"1341-1348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement"],"prefix":"10.1097","volume":"48","author":[{"given":"Yuxiu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binshen","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijin","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"20160271","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein-Barr virus-associated lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.clml.2011.07.003","article-title":"EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals","volume":"11","author":"Beltran","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"12168","DOI":"10.1038\/srep12168","article-title":"Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age","volume":"5","author":"Lu","year":"2015","journal-title":"Sci Rep"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fonc.2019.00683","article-title":"Comprehensive genomic profiling of EBV-positive diffuse large B-cell lymphoma and the expression and clinicopathological correlations of some related genes","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-021-00493-5","article-title":"Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing","volume":"11","author":"Gebauer","year":"2021","journal-title":"Blood Cancer J"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","article-title":"Molecular profiling of EBV associated diffuse large B-cell lymphoma","volume":"37","author":"Frontzek","year":"2023","journal-title":"Leukemia"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/bloodadvances.2021004515","article-title":"Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified","volume":"5","author":"Bourbon","year":"2021","journal-title":"Blood Adv"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2022.07.300","article-title":"Lineage- and stage-specific oncogenicity of IRF4","volume":"114","author":"Amanda","year":"2022","journal-title":"Exp Hematol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/cancers14174314","article-title":"IRF4 as an oncogenic master transcription factor","volume":"14","author":"Wong","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/sj.leu.2405027","article-title":"The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma","volume":"22","author":"Remstein","year":"2008","journal-title":"Leukemia"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"e27770","DOI":"10.1002\/pbc.27770","article-title":"IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children\u2019s Oncology Group trials","volume":"66","author":"Chisholm","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","article-title":"Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients","volume":"131","author":"Berg","year":"2023","journal-title":"Hum Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1002\/cam4.5828","article-title":"IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma","volume":"12","author":"Jiang","year":"2023","journal-title":"Cancer Med"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue","volume":"8","author":"Ventura","year":"2006","journal-title":"J Mol Diagn"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cncr.35072","article-title":"The genetic landscape of histologically transformed marginal zone lymphomas","volume":"130","author":"Li","year":"2024","journal-title":"Cancer"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly","volume":"122","author":"Ok","year":"2013","journal-title":"Blood"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cei.12682","article-title":"Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired","volume":"182","author":"C\u00e1rdenas","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ajh.23507","article-title":"Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy","volume":"88","author":"Ahn","year":"2013","journal-title":"Am J Hematol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/cas.12467","article-title":"Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era","volume":"105","author":"Sato","year":"2014","journal-title":"Cancer Sci"},{"key":"R34-20250608","first-page":"8947","article-title":"Clinical features and survival impact of EBV-positive diffuse large B-Cell lymphoma with different age cutoffs","volume":"24","author":"Nan","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jmoldx.2017.05.006","article-title":"Validation of a targeted RNA sequencing assay for kinase fusion detection in solid tumors","volume":"19","author":"Reeser","year":"2017","journal-title":"J Mol Diagn"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrm.2016.67","article-title":"Regulating Rho GTPases and their regulators","volume":"17","author":"Hodge","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/sj.onc.1203521","article-title":"Nonrandom 4p13 rearrangements of the RhoH\/TTF gene, encoding a GTP-binding protein, in non-Hodgkin\u2019s lymphoma and multiple myeloma","volume":"19","author":"Preudhomme","year":"2000","journal-title":"Oncogene"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:03:42Z","timestamp":1749413022000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002301","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}